Catherine Nester Discusses the BeginNGS Tool for Newborn Rare Disease Screening Awareness
August 25th 2023Catherine Nester, RN, vice president of physician and patient strategies at Inozyme Pharma, highlights the importance of newborn screening for rare diseases and the impact of the BeginNGS diagnostic tool.
Read More
Neighborhood Opportunities Linked to Child Well-Being in Primary Care
August 24th 2023Results reveal living in neighborhoods with very high Childhood Opportunity Index (COI) scores is linked with elevated odds of being up to date on preventive visits and immunizations when compared with those living in neighborhoods with very low COI scores.
Read More
Quality vs Convenience: Rural Cancer Patients Weigh Options for Surgical Care
August 17th 2023“Our study suggests that narrowly focusing on hospital volumes and tying that to insurance reimbursement might mask complexities and trade-offs in achieving the goal of optimizing patient outcomes and experiences,” lead co-author Lindsay Sabik, PhD, says.
Read More
Catherine Nester, RN, Discusses the Advancement of the BeginNGS Screening Program
August 11th 2023The BeginNGS program added 23 new founding members to the consortium and expanded to include 31 additional genetic disorders in its second phase screening, totaling 419 treatable genetic disorders.
Read More